US Supreme Court refuses to hear BMS’s Baraclude appeal

06-05-2015

US Supreme Court refuses to hear BMS’s Baraclude appeal

360b / Shutterstock.com

The US Supreme Court has rejected pharmaceutical company Bristol-Myers Squibb’s (BMS’s) appeal to review a ruling that found its patent covering a treatment for hepatitis B invalid.


Bristol-Myers Squibb; Teva; US Supreme Court; ANDA; Hepatitis B; Baraclude

LSIPR